Preformulation in Solid Dosage Form Development Dosage, Development, Solid, Form

Moji C. Adeyeye, Harry G. Brittain, "Preformulation in Solid Dosage Form Development (Drugs and the Pharmaceutical Sciences)"
Informa HealthCare; 1st edition (January 7, 2008) | English | 0824758099 | 616 pages | PDF | 8.82 MB

During the onset of any clinical trial there are many factors and variables to consider. Funding, time restraints, and regulatory agency guidelines are factors that often influence which variables will be studied, leaving other important information out of the study. Preformulation in Solid Dosage Form Development covers every topic of critical importance to the preformulation stages of drug development. Serving as a handbook or stand-alone reference, this text equips those in academia and the pharmaceutical industry with both basic and applied principles for the characterization of drugs, excipients, and products, and deals with the issues relating to predictability, identification, and product development during preformulation stages through Phase I of clinical trials.
Links
http://depositfiles.com/files/gjhc2ku2g/0824758099.rar
or
http://rapidshare.com/files/274161209/0824758099.rar